Amniotic fluid embolism

Surgical approach (obstetric team actions)

  • Call for help: senior obstetrician, anaesthetist, haematology, transfusion, ICU, neonatology; activate major obstetric haemorrhage (MOH) protocol
  • Immediate uterine management if ongoing bleeding/atony: bimanual compression, uterotonics, uterine balloon tamponade
    • Escalate to surgical haemostasis: B-Lynch/compression sutures, uterine artery ligation/internal iliac ligation (selected cases)
  • If bleeding uncontrolled or placenta accreta spectrum suspected/confirmed: proceed to hysterectomy (damage-control approach may be required)
  • If maternal cardiac arrest with fetus in utero: perimortem caesarean delivery (resuscitative hysterotomy)
    • Aim to start within 4 minutes of arrest and deliver by 5 minutes (improves maternal venous return and fetal outcome)

Anaesthetic management (procedural context)

  • Type of anaesthesia: usually requires immediate conversion to full resuscitation/GA (even if neuraxial in situ); treat as maternal collapse
    • If arrest/impending arrest: RSI with cricoid, 100% O2; avoid delays to chest compressions/defibrillation
  • Airway: cuffed ETT preferred; SGA only as a temporary rescue if intubation delayed/failed
  • Duration: unpredictable; acute resuscitation minutes, but haemorrhage control and stabilisation often hours; anticipate ICU transfer
  • How painful: not a pain-driven condition; analgesia is secondary to oxygenation, haemodynamics, and haemostasis
  • Monitoring/lines: immediate A-line, large-bore IV/rapid infuser, consider central access; continuous ETCO2 (marker of perfusion/ROSC)
  • Vasoactive support: early noradrenaline; add adrenaline if profound shock; consider vasopressin as adjunct; inotropes for RV failure
  • Coagulopathy: early balanced blood products guided by viscoelastic testing (TEG/ROTEM) if available; treat DIC aggressively

Definition and epidemiology

  • Syndrome of sudden maternal cardiovascular collapse and/or respiratory compromise with coagulopathy occurring during labour, caesarean delivery, or within ~30 minutes postpartum (can be later)
  • Rare but high mortality/morbidity; incidence commonly quoted ~1–2 per 100,000 maternities (varies by definition/registry)
  • Often a diagnosis of exclusion; may be classified as “definite/probable/possible” depending on case definition (clinical features + timing + exclusion of alternatives)

Pathophysiology (current model)

  • Not a simple mechanical embolus: thought to be an anaphylactoid/inflammatory response to fetal material entering maternal circulation → pulmonary vasoconstriction, V/Q mismatch, RV failure, hypoxia
  • Biphasic haemodynamic pattern described: early acute pulmonary hypertension/RV failure → later LV failure/cardiogenic shock
  • Coagulopathy: activation/consumption of clotting factors and platelets → DIC; uterine atony and massive haemorrhage common
  • Triggers/risk associations (not diagnostic): induction/augmentation, operative delivery, placental abruption/previa, uterine rupture, eclampsia, advanced maternal age, multiparity

Clinical presentation

  • Classical triad: hypoxia + hypotension/cardiac arrest + coagulopathy/bleeding (often within minutes)
  • Prodromal features: dyspnoea, chest pain, agitation/confusion, sense of doom, nausea/vomiting, seizures
  • Signs: sudden desaturation, bronchospasm, cyanosis, hypotension, arrhythmias, PEA/asystole; later massive PPH with oozing from puncture sites
  • Fetal compromise: sudden fetal bradycardia/late decelerations may be first sign

Differential diagnosis of peripartum collapse (must be actively excluded)

  • Massive haemorrhage (atony, abruption, uterine rupture), high/total spinal, local anaesthetic systemic toxicity (LAST)
  • Pulmonary thromboembolism, air embolism, aspiration, anaphylaxis, sepsis
  • Eclampsia/ICH, MI/aortic dissection, cardiomyopathy (PPCM), magnesium toxicity

Immediate management (maternal resuscitation priorities)

  • Recognise maternal collapse; call for help; allocate roles; activate MOH; bring defib, airway trolley, rapid infuser, blood fridge access
  • A: 100% O2; early intubation/ventilation; suction; consider aspiration; maintain left uterine displacement until delivery
  • B: ventilate to normocapnia; consider high PEEP cautiously (RV failure risk); treat bronchospasm if present
  • C: follow ALS with obstetric modifications; high-quality CPR; early defibrillation if shockable; adrenaline per ALS; treat reversible causes
  • Haemodynamics: rapid volume resuscitation while avoiding overload; early vasopressors; consider inotropes for RV dysfunction
  • If arrest and pregnancy ≥20 weeks or uterus at/above umbilicus: perimortem caesarean delivery at 4 minutes if no ROSC

Coagulopathy and haemorrhage management

  • Send urgent labs: FBC, PT/APTT, fibrinogen, group & screen/crossmatch, ABG/lactate, calcium; repeat frequently
  • Early tranexamic acid for PPH (e.g., 1 g IV then 1 g if bleeding continues/restarts within 24 h) unless contraindicated
  • Balanced transfusion: RBC + FFP + platelets; target fibrinogen aggressively (cryoprecipitate or fibrinogen concentrate per local protocol)
  • Correct ionised hypocalcaemia from citrate; warm patient/fluids; avoid dilutional coagulopathy
  • Use TEG/ROTEM if available to direct products (e.g., low FIBTEM A5 suggests fibrinogen replacement)
  • Uterine atony management in parallel: uterotonics, tamponade, surgery; consider interventional radiology if stable enough

Cardiorespiratory support and advanced therapies

  • Echo (POCUS/TOE) can be diagnostic and guide therapy: RV dilation/strain, LV dysfunction, exclude tamponade
  • Consider pulmonary vasodilators for severe pulmonary hypertension/RV failure (specialist decision): inhaled nitric oxide or prostacyclin
  • Mechanical circulatory support: ECMO (VA for cardiogenic shock/arrest; VV for refractory hypoxaemia) in selected centres; balance against bleeding/DIC
  • ICU care: ongoing haemodynamic monitoring, ventilation, renal support, neuroprotection post-arrest, thromboprophylaxis when safe

Investigations and diagnosis (practical FRCA angle)

  • Diagnosis is clinical + temporal relationship + exclusion of other causes; no single confirmatory bedside test
  • ABG: hypoxaemia, metabolic acidosis, raised lactate; ETCO2 may fall abruptly during collapse
  • Coagulation: low fibrinogen is common and can be profound; thrombocytopenia; prolonged PT/APTT in DIC
  • CXR: pulmonary oedema/ARDS pattern may develop; ECG: non-specific; troponin may rise in shock
  • “Tests” sometimes discussed (not routine/limited utility): serum tryptase (if anaphylaxis in differential), complement activation markers; fetal squames in pulmonary vessels are non-specific

Prognosis and follow-up

  • High maternal morbidity: hypoxic brain injury, ARDS, renal failure, massive transfusion complications; fetal outcome depends on speed of maternal resuscitation/delivery
  • Debriefing, incident review, documentation; counselling regarding recurrence risk (generally low but uncertain); plan for future pregnancy with high-risk obstetric/anaesthetic input
You are called to labour ward: a woman becomes suddenly breathless, hypotensive and desaturates immediately after delivery. Talk through your immediate management.

Structured maternal collapse response with simultaneous resuscitation, diagnosis, and haemorrhage control.

  • Call for help and declare maternal collapse; activate MOH; allocate roles (airway, compressions, drugs, lines, documentation, runner)
  • A/B: 100% O2, airway manoeuvres, prepare RSI and intubation; ventilate; check ETCO2; consider aspiration and suction
  • C: obtain large-bore IV access, start vasopressor early (noradrenaline), fluid bolus judiciously; if arrest start ALS immediately
  • Simultaneously consider differentials: haemorrhage, high spinal, LAST, anaphylaxis, PTE/air embolus, sepsis, eclampsia; treat reversible causes
  • Send urgent bloods (FBC, coag, fibrinogen, ABG, calcium) and request blood products; start TXA if bleeding/PPH
  • Early echo/POCUS if available to guide (RV failure vs LV failure) and tailor inotropes/vasopressors
What are the key clinical features that make you suspect amniotic fluid embolism, and what else must you exclude?
  • Suspect AFE when there is abrupt onset of hypoxia/respiratory distress, hypotension/cardiac arrest, and coagulopathy/bleeding temporally related to labour/delivery/early postpartum
  • Often fetal distress occurs early (sudden bradycardia) and maternal DIC/PPH follows
  • Exclude: massive obstetric haemorrhage (atony/abruption/rupture), high/total spinal, LAST, anaphylaxis, pulmonary thromboembolism/air embolism, aspiration, sepsis, eclampsia/ICH, PPCM/MI/aortic dissection
Explain the pathophysiology of AFE and how it influences your haemodynamic management.
  • Likely an anaphylactoid/inflammatory response to fetal material → acute pulmonary vasoconstriction and pulmonary hypertensionRV failure and reduced LV preload → hypotension/collapse
  • Later LV dysfunction/cardiogenic shock may occur; management must be dynamic (vasopressors + inotropes guided by echo)
  • Avoid excessive PEEP/overdistension that worsens RV afterload; consider pulmonary vasodilators in specialist settings
How would you manage the coagulopathy associated with AFE?
  • Treat as DIC with massive haemorrhage: activate MOH, rapid lab assessment and frequent reassessment
  • Give TXA early for PPH; transfuse balanced components (RBC/FFP/platelets) and replace fibrinogen early (cryo or fibrinogen concentrate per protocol)
  • Use TEG/ROTEM if available; correct calcium, temperature, and acidosis; avoid dilution and maintain uterine tone/surgical haemostasis
A woman arrests on the labour ward at 36 weeks. Describe the obstetric modifications to ALS and the role of perimortem caesarean delivery.
  • High-quality CPR with manual left uterine displacement; early airway control and 100% oxygen; defibrillation as per standard ALS
  • If no ROSC rapidly, perform perimortem caesarean (resuscitative hysterotomy) aiming to start by 4 minutes and deliver by 5 minutes
  • Rationale: improves maternal venous return and cardiac output by relieving aortocaval compression; may improve fetal survival
You suspect AFE but the patient is profoundly hypoxic and hypotensive. What monitoring and bedside investigations will help you guide therapy in real time?
  • Continuous ETCO2 (perfusion/CPR quality/ROSC), invasive arterial BP, urine output, temperature; frequent ABGs including lactate and ionised calcium
  • POCUS/echo to assess RV size/function, LV function, volume status, and exclude tamponade; lung ultrasound for oedema/pneumothorax
  • Viscoelastic testing (TEG/ROTEM) to guide blood products and fibrinogen replacement
Discuss the differential diagnosis of sudden collapse shortly after neuraxial anaesthesia for caesarean section and how you would distinguish them from AFE.
  • High/total spinal: rapid hypotension, bradycardia, high sensory block, difficulty breathing due to motor block; usually no DIC/oozing
  • LAST: tinnitus/metallic taste/seizures then arrhythmias; treat with lipid emulsion; timing with local anaesthetic dosing
  • Anaphylaxis: bronchospasm, urticaria/angioedema, hypotension; tryptase may help later; coagulopathy not typical early
  • Haemorrhage: visible bleeding/uterine atony, falling Hb, shock; coagulopathy may be dilutional/consumptive later
  • AFE: sudden hypoxia + hypotension/collapse with early fetal distress and rapid DIC/PPH; often no preceding neuraxial warning signs
What advanced therapies might be considered in refractory AFE, and what are the limitations?
  • Inhaled pulmonary vasodilators (NO/prostacyclin) for severe pulmonary hypertension/RV failure; requires expertise and monitoring
  • ECMO (VA for shock/arrest; VV for refractory hypoxaemia) in appropriate centres; major limitation is bleeding risk in DIC and need for anticoagulation
  • Massive transfusion and damage-control surgery may be required; early ICU involvement is essential
Outline your management of sudden maternal collapse on the labour ward.

Commonly examined as an A–E + obstetric-specific ALS answer with parallel MOH activation and perimortem delivery decision-making.

  • Immediate actions: call for help, emergency buzzer, bring defib/airway kit, allocate roles, document times, consider reversible causes (4 Hs/4 Ts plus obstetric causes)
  • A/B: 100% O2, intubate early, ventilate, confirm with capnography; treat bronchospasm; consider aspiration
  • C: ALS algorithm; IV/IO access; vasopressors; bloods; activate MOH; TXA if bleeding; correct calcium/temperature
  • Obstetric modifications: left uterine displacement; perimortem caesarean if ≥20 weeks and no ROSC by 4 minutes
  • Post-ROSC: ICU transfer, targeted temperature management as per local policy, ongoing haemorrhage control, neuroprognostication later
Discuss the causes of coagulopathy in obstetrics and how you would manage DIC in a bleeding parturient.
  • Causes: placental abruption, severe pre-eclampsia/HELLP, sepsis, retained dead fetus, AFE, massive haemorrhage/dilution, acute fatty liver of pregnancy
  • Management: treat cause + haemostatic resuscitation (RBC/FFP/platelets) + early fibrinogen replacement; TXA for PPH; viscoelastic-guided therapy where available
  • Supportive: warming, calcium, correct acidosis, maintain uterine tone and surgical haemostasis; ICU involvement
Describe the anaesthetic considerations for perimortem caesarean delivery.
  • Priority is maternal resuscitation; procedure is performed where arrest occurs; do not delay for transfer to theatre
  • Airway: RSI with cuffed ETT if feasible without interrupting compressions; otherwise continue BVM/SGA as bridge
  • Circulation: ongoing ALS; anticipate massive haemorrhage; MOH activation; rapid infuser; vasopressors; correct coagulopathy
  • After delivery: expect improved venous return/CPR efficacy; continue resuscitation; neonatal team receives baby

0 comments